Brief Behavioral Therapy for Insomnia(BBTi) in Middle-aged and Older Adults With Chronic Insomnia
Launched by NATIONAL CHENG-KUNG UNIVERSITY HOSPITAL · Oct 5, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program called Brief Behavioral Therapy for Insomnia (BBTi) to see if it can help middle-aged and older adults who have trouble sleeping. The program lasts for four weeks and aims to improve sleep quality and lower stress levels. The researchers are currently looking for participants aged 40 and older who have been experiencing sleep issues. It’s important that participants are able to understand the study and give their consent to take part, but those with cognitive impairment are not eligible.
If you decide to join the study, you’ll be part of a program designed to help you sleep better. Throughout the trial, you’ll learn techniques to improve your sleep habits. This could be a great opportunity to find relief from chronic insomnia and enhance your overall well-being. If you’re interested and meet the criteria, consider reaching out to the study team for more information.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • individuals aged 40 years and above,
- • experiencing sleep disturbances,
- • willing to participate in the research project and provide informed consent
- Exclusion Criteria:
- • ●Cognitive impairment
About National Cheng Kung University Hospital
National Cheng Kung University Hospital is a leading academic medical institution in Taiwan, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources and expertise in various medical fields to facilitate groundbreaking studies that enhance patient care and medical knowledge. Committed to adhering to the highest ethical standards and regulatory guidelines, National Cheng Kung University Hospital fosters collaborations with researchers, healthcare professionals, and industry partners to drive the development of new therapies and improve health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tainan City, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported